Eli Lilly’s $1 billion investment in Telangana is reshaping India’s pharma landscape, focusing on high-skill manufacturing, job creation, and global scale delivery, with implications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback